11F, 365 FuXing N. Rd., Songshan District, Taipei City, Taiwan, 10543
Eli Lilly and Company is a leading, innovation-driven corporation committed to developing a growing portfolio of best-in-class and first-in-class pharmaceutical products that help people live longer, healthier, and more active lives. Lilly products treat depression, schizophrenia, attention-deficit hyperactivity disorder, diabetes, osteoporosis, cancer, and many other conditions. We are committed to providing answers that matter through medicines and information for some of the world’s most urgent medical needs.
Lilly employs more than 41,000 people worldwide and markets our medicines in 125 countries. We have major research and development facilities in 6 countries and conduct clinical trials in more than 55 countries.
Founded in 1966, Lilly Taiwan is dedicated to providing best-in-class products and exceptional service to our customers in Taiwan. In the future, we will work on reinforcing our relationships with the local government, medical societies, and advocacy groups in the hope of contributing more to Taiwan’s life sciences industry. At the same time, we will conduct philanthropic activities because we believe that we have a responsibility to be a good corporate citizen within our communities.